The Cooling And Surviving Septic Shock Study (CASS)

Stopped early · Phase 2/Phase 3

Conditions studied: Septic Shock

In brief

Septic shock is in critically ill patients is a condition associated with a high rate of organ failure and hereto attributable mortality \~45-55% Hypothesis: Mild Induced Hypothermia reduces the mortality of critically ill patients with septic shock by reducing organ metabolism, counteracting on microcirculatory thrombosis, genetically downregulating tissue apoptosis and by reducing bacterial growth rate and toxin production.

Key facts

Study ID
NCT01455116
Run by
Danish Procalcitonin Study Group
People needed
433
Starts
2011-11-01
Expected to finish
2016-11-01
Last updated by the study team
2016-11-22

Who can join

Age: 50 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.